Resources ## Breadcrumb 1. [Home](/) 2. [Resources](/resources/resource-center) 3. [Resource Center](/resources/resource-center) # Connect Your Serialization System to the TraceLink Network for Rapid DSCSA Compliance Strategy Brief ![banner-image](https://www.tracelink.com/sites/default/files/2023-01/GettyImages-75675775-1.png) - [Download PDF](/node/23826/pdf) - [Share](#) - [ LinkedIn ](https://www.linkedin.com/shareArticle?mini=true&url=https://www.tracelink.com/resources/resource-center/connect-your-serialization-system-to-traceLink-network-strategy-brief&title=Connect Your Serialization System to the TraceLink Network for Rapid DSCSA Compliance&summary=Read this strategy brief to discover the fastest path to DSCSA compliance!&source=TraceLink "LinkedIn") - [ Facebook ](https://www.facebook.com/share.php?u=https://www.tracelink.com/resources/resource-center/connect-your-serialization-system-to-traceLink-network-strategy-brief&t=Connect Your Serialization System to the TraceLink Network for Rapid DSCSA Compliance "Facebook") - [ Mail ](mailto:?subject=Connect Your Serialization System to the TraceLink Network for Rapid DSCSA Compliance+|+TraceLink&body=https://www.tracelink.com/resources/resource-center/connect-your-serialization-system-to-traceLink-network-strategy-brief "Mail") - [ Twitter ](https://twitter.com/intent/tweet?text=Connect Your Serialization System to the TraceLink Network for Rapid DSCSA Compliance https://www.tracelink.com/resources/resource-center/connect-your-serialization-system-to-traceLink-network-strategy-brief&via=TraceLink "Twitter") #### Table of contents ##### *Fill out the form to download now!* ![L5 Image](https://www.tracelink.com/sites/default/files/2023-05/L5-Image.png)Under the U.S. Drug Supply Chain Security Act, pharmaceutical manufacturers and their trading partners must establish secure, electronic, and 100% interoperable exchange of serialized compliance data by November 27, 2023. And that deadline is coming up fast! To meet DSCSA compliance requirements, manufacturers must establish new integrations with all downstream trade partners to replace the ASNs currently used to send lot-level compliance data. For MAHs not using the TraceLink network, building the new integrations will cost $5,000-$15,000 and take 4-8 weeks for each customer/trade partner relationship, and organizations that have not started yet are unlikely to meet the November deadline. The good news is that TraceLink has the answer: TraceLink can enable any pharmaceutical manufacturer to send the required EPCIS data to all downstream partners with a single integration through the TraceLink network. It’s fast, easy and you can keep your existing serialization software. TraceLink can implement L5 network capabilities in 3-5 weeks and ensure that your organization is compliant before the November deadline. Read our new strategy brief and see how it works! The TraceLink "Integrate Once, Interoperate with Everyone™" capability means manufacturers can establish a single connection into the network using their preferred transaction type and format. The manufacturer does not have to worry about the ever-changing requirements throughout its customer base. Beyond DSCSA compliance, customers on the TraceLink L5 network experience additional benefits: - **Faster:** With more than 290,000 network members, all or most of MAHs’ trading partners are already fully integrated into the TraceLink network, simplifying trade partner onboarding and authentication. - **Better:** The TraceLink network and DSCSA compliance solutions are built on a highly scalable cloud platform to process data-intensive EPCIS transactions at no additional cost. - **Lowest Total Cost Ownership:** Purpose-built solutions on the network provide interoperable data exchange at the lowest integration costs. - **Future Proof:** Continuous investment in network solutions for digital recalls, supply network orchestration, drug shortage predictions, and multienterprise integration extends value beyond serialization and compliance. Fill out the form to download the strategy brief and learn more! [Solution Brief](/category/solution-brief)[US Drug Supply Chain Security Act](/category/us-drug-supply-chain-security-act)[DSCSA for Dispensers](/category/dscsa-dispensers), [DSCSA for Manufacturers](/category/dscsa-manufacturers) #### Table of contents Download the strategy brief now! Fill out the form to download now. document.addEventListener("DOMContentLoaded", function() { // Delay the execution by 2 seconds (2000 milliseconds) setTimeout(function() { (function() { 'use strict'; // Load Marketo form MktoForms2.loadForm("//go.tracelink.com", "776-BAW-230", 2253); })(); // Wait until the Marketo form is loaded MktoForms2.whenReady(function(form) { var formElement = document.getElementById('mktoForm_2253'); if (!formElement) { console.error("Form with id 'mktoForm_2253' not found."); return; } var formLocation = formElement.querySelector("input[name=formLocation]"); // Get the current URL and set the formLocation field if (formLocation) { var currentURL = window.location.href; formLocation.value = currentURL; } // Add onSuccess handler form.onSuccess(function(values, followUpUrl) { var formElem = form.getFormElem()[0]; if (formElem) { formElem.style.display = 'none'; } else { console.warn("Form element could not be found to hide it."); } var confirmMessage = document.getElementById('confirmform'); if (confirmMessage) { confirmMessage.style.display = 'block'; } else { console.warn("Confirmation message with id 'confirmform' not found."); } return false; // Prevent the form from submitting normally }); }); }, 2000); // Delay for 2 seconds }); **Thank you. Check your email for a copy of the content you requested.** ##### Related Content [ ![Manufacturers](https://www.tracelink.com/sites/default/files/styles/resize_image_style_640_480/public/2024-03/For%20Internal%2087.png.webp?itok=RRDngvZe) ](https://www.tracelink.com/resources/resource-center/dscsa-2023-webinar-series-for-manufacturers-and-wholesale-distributors) ##### DSCSA 2023 Webinar Series for Manufacturers How to ensure supply and create business value with DSCSA compliance for drug manufacturers. [View More](https://www.tracelink.com/resources/resource-center/dscsa-2023-webinar-series-for-manufacturers-and-wholesale-distributors) [ ![event](https://www.tracelink.com/sites/default/files/styles/resize_image_style_640_480/public/2023-01/GettyImages-530685719-1.png.webp?itok=K2zwQZ1H) ](/resources/resource-center/elizabeth-waldorf-dscsa-compliance-interview) ##### Interoperability Standards Expert: DSCSA Compliance Requires a Re-Examination of Business Processes Elizabeth Waldorf, Director of Global Traceability and Standards at TraceLink, explains why pharma supply chain stakeholders need to update business processes to reduce DSCSA 2023 compliance errors. Read the interview and watch the video! [View More](/resources/resource-center/elizabeth-waldorf-dscsa-compliance-interview) [ ![event](https://www.tracelink.com/sites/default/files/styles/resize_image_style_640_480/public/2023-01/GettyImages-171592241-1.png.webp?itok=B0vloiqf) ](/resources/resource-center/dscsa-2023-handle-the-influx-of-dscsa-compliance-exceptions) ##### DSCSA 2023: How to Handle the Influx of DSCSA Compliance Exceptions With less than seven months to go, organizations across the end-to-end pharmaceutical supply chain—including manufacturers, wholesale distributors, third-party logistics providers, and dispensers—need to act with urgency and prepare now. [View More](/resources/resource-center/dscsa-2023-handle-the-influx-of-dscsa-compliance-exceptions)